Visudyne is a medicine containing the active ingredient(s) verteporfin. On this page you will find out more about Visudyne, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: verteporfin
Information for medicine and pack size:
Visudyne 15 mg powder for injection, 1 vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
VISUDYNE is indicated for the treatment of age-related macular degeneration in patients with predominately classic subfoveal choroidal neovascularisation. INDICATIONS AS AT 31 JULY 2001: VISUDYNE is indicated for the treatment of patients with predominatly classic subfoveal choroidal neovascularisation due to age-related macular degeneration (AMD), or with subfoveal choroidal neovascularisation caused by other macular diseases. INDICATIONS AS AT 27 JUNE 2002: VISUDYNE is indicated for the treatment of patients with predominantly classic or occult subfoveal choroidal neovascularisation due to age-related macular degeneration (AMD), or with subfoveal choroidal neovascularisation caused by other macular diseases.
Table of characteristics
|Visual appearance||Dark green cake.|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous Infusion|
1 x vial: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||4 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Visudyne | myVMC
Visudyne is a medicine containing verteporfin, used to treat neovascularisation in age related macula degeneration (AMD) and other diseases of the macula.
Read more on myVMC – Virtual Medical Centre website
Visudyne Powder for infusion - myDr.com.au
Visudyne Powder for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results